Step Pharma is a clinical stage precision oncology company. Dencatistat (STP938) is a first in class, oral, selective CTPS1 inhibitor currently in Phase I/II clinical development in essential thrombocythemia, biomarker selected solid tumours and relapsed/refractory lymphoma.

imunaris is a forward-thinking Swiss startup committed to facilitating commercial access for pharmaceuticals, medical devices, and diagnostics. With a focus on agile and efficient methods, we offer tailored solutions to conquer the complexities of the Swiss healthcare market.

nuantic offers AI-guided lead optimization to biotech and pharma customers developing protein- and peptide-based therapeutics. We're able to optimize affinity, developability and aspects of immunogenicity with outstanding success rates with 10x less effort as compared to traditional methods.